Table 2.
Regimen | Percentage relapse assessed 12 weeks after the completion of treatment for |
||
---|---|---|---|
2.5 months | 3.5 months | 4.5 months | |
Isoniazid/rifampicin/pyrazinamide | 100 (10/10) | 50 (5/10) | 0 (15/15) |
Isoniazid/rifampicin/pyrazinamide + simvastatin | 50 (5/10) | 20 (2/10) | 0 (15/15) |
Relapse is defined as having culture-positive lungs at the time of assessment.